Search Top Featured Websites...
Breaking Top Featured Content:
Breaking Top Featured Content:
Will the FDA change how it vets drugs following the Alzheimer’s debacle?
Nature, Published online: 13 May 2022; doi:10.1038/d41586-022-01316-8
The accelerated approval of aducanumab has triggered US lawmakers to push for more oversight from the agency.